NASDAQ:INMD InMode Q2 2026 Earnings Report $14.35 -0.19 (-1.31%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$14.52 +0.17 (+1.16%) As of 09/18/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast InMode EPS ResultsActual EPS$0.35Consensus EPS $0.35Beat/MissBeat by +$0.00One Year Ago EPS$0.47InMode Revenue ResultsActual Revenue$95.59 millionExpected Revenue$94.89 millionBeat/MissBeat by +$698.00 thousandYoY Revenue GrowthN/AInMode Announcement DetailsQuarterQ2 2026Date8/5/2026TimeBefore Market OpensConference Call DateWednesday, August 5, 2026Conference Call Time9:30AM ETUpcoming EarningsInMode's Q3 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedulesConference Call ResourcesPress Release (6-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(6-K) InMode Earnings HeadlinesInMode: Reasonably Valued But With Too Much DramaSeptember 16, 2026 | seekingalpha.comInMode Says Unsolicited Takeover Proposal Expires Without DealSeptember 16, 2026 | tipranks.comA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio. | Stansberry Research (Ad)InMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by AnalystsSeptember 10, 2026 | americanbankingnews.comInMode Advances RF Microneedling Comfort with the Launch of Morpheus8 CoolSeptember 9, 2026 | prnewswire.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)August 9, 2026 | theglobeandmail.comSee More InMode Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like InMode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on InMode and other key companies, straight to your email. Email Address About InModeInMode (NASDAQ:INMD) (NASDAQ: INMD) is an Israel-based medical technology company that develops, manufactures and markets energy-based platforms for minimally invasive and non-invasive aesthetic and medical treatments. Its technologies are designed for use by physicians and other healthcare professionals in areas including facial rejuvenation, skin resurfacing, body contouring, hair removal and women’s health. The company’s product portfolio includes radiofrequency-based systems such as BodyTite and FaceTite for tissue remodeling and contouring, Morpheus8 for fractional skin treatment, and multi-application platforms such as EmpowerRF and Optimas. InMode sells its systems and related consumables primarily through a direct sales force and distributors to medical practices, clinics and hospitals. Founded in 2008 and headquartered in Yokneam, Israel, InMode serves customers across North America, Europe, Asia-Pacific, Latin America and other international markets. The company completed its initial public offering on the Nasdaq stock exchange in 2019. Moshe Mizrahy, a co-founder of InMode, serves as the company’s chief executive officer and chairman.View InMode ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in FocusPriced for a Pullback or More Gains? These 3 Stocks Are Testing the LimitsCoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
